# iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study

> **NCT04624685** · — · UNKNOWN · sponsor: **Glaukos Corporation** · enrollment: 475 (estimated)

## Conditions studied

- Glaucoma, Open-Angle

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04624685
- **Lead sponsor:** Glaukos Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-15
- **Primary completion:** 2021-01-20
- **Final completion:** 2021-12
- **Target enrollment:** 475 (ESTIMATED)
- **Last updated:** 2021-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04624685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04624685, "iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04624685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*